左侧乳腺癌放疗中自由呼吸与深吸气屏气技术的胃部副作用及胃剂量学分析
该研究分析了124例左侧乳腺癌术后辅助放疗患者的临床特征与胃肠道副作用,并评估剂量学参数。结果显示两组在年龄、T分期、N分期、激素受体、HER2、手术方式、分割方案及化疗情况上无统计学显著差异,但较大胃体积和较高分次剂量(Dmax/F)与急性放疗毒性风险 statistically 显著增加相关。使用DIBH门控技术(FB/DIBH)降低了消化道反应发生率。
要点
- 较大胃体积和较高分次剂量(Dmax/F)与急性放疗毒性风险 statistically 显著增加相关。
- 使用DIBH门控技术(FB/DIBH)降低了消化道反应发生率。
- 作者建议治疗前避免大量进食,条件允许的中心应实施DIBH治疗,制定放疗计划时考虑胃剂量限制。
核心结论
- 为减少乳腺放疗后胃部副作用,治疗前应避免大量进食。
- 条件满足的中心应实施DIBH治疗以减少放疗副作用。
- 制定放疗计划时应考虑胃剂量限制,尤其是接受大分割放疗的患者。
研究设计与样本
- 本研究分析了124例在本院接受术后辅助放疗的左侧乳腺癌患者(LSBCP)的临床特征,并询问治疗后胃肠道副作用,同时评估剂量学参数。
主要发现
- 两组在年龄、T分期、N分期、激素受体、人表皮生长因子受体-2(HER2)、手术方式、分割方案和化疗情况方面无统计学显著差异。
- 较大胃体积和较高分次剂量(Dmax/F)与急性放疗毒性风险 statistically 显著增加相关。
- 使用DIBH门控技术(FB/DIBH)降低了消化道反应发生率。
临床怎么用
- 作者建议治疗前避免大量进食以减少乳腺放疗后胃部副作用。
- 作者建议条件满足的中心应实施DIBH治疗以减少放疗副作用。
- 作者建议制定放疗计划时考虑胃剂量限制,尤其是接受大分割放疗的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adjuvant radiotherapy following surgery reduces the local recurrence and improves the prognosis. However, a considerable part of patients developed digestive reaction in daily treatment. In order to explore the correlation between breast radiotherapy and gastric toxicity, we investigated the clinic symptoms and stomach dose during DIBH or FB mode while left-sided breast cancer patients (LSBCP) receiving radiotherapy. METHODS: In the study, 124 LSBCP received adjuvant radiotherapy after surgery at our department were analyzed clinical characteristics and enquired about gastrointestinal side effects after treatment. Moreover, dosimetric parameters were assessed. RESULTS: There was no statistically significant difference between the two groups in age, T staging, N staging, hormone receptors, human epidermal receptor-2 (HER2), surgical methods, fractionated regimen, and chemotherapy conditions. However, larger stomach volumes and higher fractionated dose (Dmax/F) were associated with a statistically significantly greater risk for acute radiotherapy toxicity. In addition, the use of the DIBH gating technique (FB/DIBH) reduced the incidence of digestive reactions. CONCLUSION: In order to cut down gastric side effects after breast radiotherapy, large meals should be avoided before treatment. DIBH treatment should be implemented in centers where conditions are satisfied to reduce radiotherapy side effects. Furthermore, dose limitation in stomach should be considered when the radiotherapy plan was formulated, especially for the patients treated with hypofractionated radiotherapy.
引用
- Yang D, Piao Y, Yuan F, et al. Gastric side effects and the stomach dosimetric analysis in left-sided breast cancer radiotherapy in free-breathing and deep inspiration breath-hold technique. Radiat Oncol. 2022. PMID: 34980180. doi:10.1186/s13014-021-01963-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。